Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of NBI-1117570 in healthy adults
NL-OMON60425Phase 1Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of NBI-1117570, sponsored by Neurocrine Biosciences. Primary endpoint: Primary endpoint(s). Started Mar 2024; status: completed.
02
Drugs
NBI-1117570
Beyond the preview
Go deeper on NL-OMON60425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60425.